Advanced Biomedical Research

Cloning, expression, purification and characterisation of Erwinia carotovora L-asparaginase in Escherichia coli

Authors

Department of Anatomical Sciences and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: For the past 30 years, bacterial L-asparaginases have been used as therapeutic agents in the treatment of acute childhood lymphoblastic leukemia. It is found in a variety of organisms such as microbes, plants and mammals. Their intrinsic low-rate glutaminase activity, however, causes serious side-effects, including neurotoxicity, hepatitis, coagulopathy and other dysfunctions. Erwinia carotovora asparaginase shows decreased glutaminase activity, so it is believed to have fewer side-effects in leukemia therapy. Our aim was to clone, express, purify and characterize E. carotovora asparaginase.
Materials and Methods: L-asparaginase from E. carotovora NCYC 1526 (ErA) was cloned and expressed in Escherichia coli strain BL21 (DE3). The enzyme was purified to homogeneity by affinity chromatography. Various conditions were tested to maximize the production of recombinant asparaginase in E. coli.
Results: A new L. asparaginase from E. carotovora NCYC 1526 (ErA) was successfully cloned, expressed and purified in E. coli BL21 (DE3). The specific activity of the enzyme was 430 IU/mg.
Conclusion: The results of the present work form the basis for a new engineered form of ErA for future therapeutic use, which could be extended with crystallographic studies.

Keywords

1. Campbell HA, Mashburn LT, Boyse EA, Old LJ. Two L-asparaginases from Escherichia coli B. Their separation, purification, and antitumor activity. Biochemistry 1967;6:721-30.  Back to cited text no. 1
    
2. Duval M, Suciu S, Ferster A, Rialland X, Nelken B, Lutz P, et al. Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: Results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial. Blood 2002;99:2734-9.  Back to cited text no. 2
    
3. Gökbuget N, Hoelzer D. Treatment of adult acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2006;1:133-41.  Back to cited text no. 3
    
4. Verma N, Kumar K, Kaur G, Anand S. L-asparaginase: A promising chemotherapeutic agent. Crit Rev Biotechnol 2007;27:45-62.  Back to cited text no. 4
    
5. Lee SM, Wroble MH, Ross JT. L-asparaginase from Erwinia carotovora. An improved recovery and purification process using affinity chromatography. Appl Biochem Biotechnol 1989;22:1-11.  Back to cited text no. 5
    
6. Ollenschläger G, Roth E, Linkesch W, Jansen S, Simmel A, Mödder B. Asparaginase-induced derangements of glutamine metabolism: The pathogenetic basis for some drug-related side-effects. Eur J Clin Invest 1988;18:512-6.  Back to cited text no. 6
    
7. Kristiansen T, Einarsson M, Sundberg L, Porath J. Purification of L-asparaginase from E. coli by specific adsorption and desorption. FEBS Lett 1970;7:294-6.  Back to cited text no. 7
    
8. Kozak M, Borek D, Janowski R, Jaskólski M. Crystallization and preliminary crystallographic studies of five crystal forms of Escherichia coli L-asparaginase II (Asp90Glu mutant). Acta Crystallogr D Biol Crystallogr 2002;58:130-2.  Back to cited text no. 8
    
9. Avramis VI, Tiwari PN. Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia. Int J Nanomedicine 2006;1:241-54.  Back to cited text no. 9
    
10. Distasio JA, Niederman RA, Kafkewitz D, Goodman D. Purification and characterization of L-asparaginase with anti-lymphoma activity from Vibrio succinogenes. J Biol Chem 1976;251:6929-33.  Back to cited text no. 10
    
11. Narta UK, Kanwar SS, Azmi W. Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia. Crit Rev Oncol Hematol 2007;61:208-21.  Back to cited text no. 11
    
12. Krasotkina J, Borisova AA, Gervaziev YV, Sokolov NN. One-step purification and kinetic properties of the recombinant L-asparaginase from Erwinia carotovora. Biotechnol Appl Biochem 2004;39:215-21.  Back to cited text no. 12
    
13. Aung HP, Bocola M, Schleper S, Röhm KH. Dynamics of a mobile loop at the active site of Escherichia coli asparaginase. Biochim Biophys Acta 2000;1481:349-59.  Back to cited text no. 13
    
14. Aghaiypour K, Wlodawer A, Lubkowski J. Do bacterial L-asparaginases utilize a catalytic triad Thr-Tyr-Glu? Biochim Biophys Acta 2001;1550:117-28.  Back to cited text no. 14
    
15. Aghaiypour K, Wlodawer A, Lubkowski J. Structural basis for the activity and substrate specificity of Erwinia chrysanthemi L-asparaginase. Biochemistry 2001;40:5655-64.  Back to cited text no. 15
    
16. Ahlke E, Nowak-Göttl U, Schulze-Westhoff P, Werber G, Börste H, Würthwein G, et al. Dose reduction of asparaginase under pharmacokinetic and pharmacodynamic control during induction therapy in children with acute lymphoblastic leukaemia. Br J Haematol 1997;96:675-81.  Back to cited text no. 16
    
17. Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med 2009;360:2730-41.  Back to cited text no. 17
    
18. Boos J, Werber G, Ahlke E, Schulze-Westhoff P, Nowak-Göttl U, Würthwein G, et al. Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations. Eur J Cancer 1996;32A:1544-50.  Back to cited text no. 18
    
19. Liang DC, Hung IJ, Yang CP, Lin KH, Chen JS, Hsiao TC, et al. Unexpected mortality from the use of E. coli L-asparaginase during remission induction therapy for childhood acute lymphoblastic leukemia: A report from the Taiwan Pediatric Oncology Group. Leukemia 1999;13:155-60.  Back to cited text no. 19
    
20. Sambrook J, Fritsch EF, Maniatis T. In: Nolan C, editor. Molecular Cloning: a Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Laboratory; 1989.  Back to cited text no. 20
    
21. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.  Back to cited text no. 21
    
22. Balcão VM, Mateo C, Fernández-Lafuente R, Malcata FX, Guisán JM. Structural and functional stabilization of L-asparaginase via multisubunit immobilization onto highly activated supports. Biotechnol Prog 2001;17:537-42.  Back to cited text no. 22
    
23. Wriston JC Jr, Yellin TO. L-asparaginase: A review. Adv Enzymol Relat Areas Mol Biol 1973;39:185-248.  Back to cited text no. 23
    
24. Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD, et al. In: Walker JM, editor. The Proteomics Protocols Handbook. Totowa, NJ: Humana Press; 2005.p. 571-607.  Back to cited text no. 24
    
25. Gilbert HJ, Blazek R, Bullman HM, Minton NP. Cloning and expression of the Erwinia chrysanthemi asparaginase gene in Escherichia coli and Erwinia carotovora. J Gen Microbiol 1986;132:151-60.  Back to cited text no. 25
    
26. Liu JJ, Li J, Wu WT, Hu MQ. Cloning and expression of the E. coli asparaginase gene in Escherichia coli. J Chin Pharm Univ 1996;27:696-700.  Back to cited text no. 26
    
27. Papageorgiou AC, Posypanova GA, Andersson CS, Sokolov NN, Krasotkina J. Structural and functional insights into Erwinia carotovora L-asparaginase. FEBS J 2008;275:4306-16.  Back to cited text no. 27
    
28. Kotzia GA, Labrou NE. Cloning, expression and characterisation of Erwinia carotovora L-asparaginase. J Biotechnol 2005; 119:309-23.  Back to cited text no. 28
    
29. Oza VP, Parmar PP, Patel DH, Subramanian RB. Cloning, expression and characterization of l-asparaginase from Withania somnifera L. for large scale production. 3 Biotech 2011;1:21-6.  Back to cited text no. 29
    
30. Khushoo A, Pal Y, Singh BN, Mukherjee KJ. Extracellular expression and single step purification of recombinant Escherichia coli L-asparaginase II. Protein Expr Purif 2004;38:29-36.  Back to cited text no. 30
    
31. Stecher AL, de Deus PM, Polikarpov I, Abrahão-Neto J. Stability of L-asparaginase: An enzyme used in leukemia treatment. Pharm Acta Helv 1999;74:1-9.  Back to cited text no. 31
    
32. Cammack KA, Marlborough DI, Miller DS. Physical properties and subunit structure of L-asparaginase isolated from Erwinia carotovora. Biochem J 1972;126:361-79.  Back to cited text no. 32
Advanced Biomedical Research
Volume 2014, February
February 2014
Pages 1-6